TG Therapeutics | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Alaunos Therapeutics USD 4K 822K 2024-10
Amgen USD 20.48B 2.53B 2025-06
Ardelyx USD 81.72M 3.89M 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
Bayer EUR 29.78B 1.82B 2025-06
Biogen USD 3.18B 2.11B 2025-06
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Dynavax Technologies USD 118.23M 49.85M 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
J&J USD 56.9B 6.58B 2025-03
Novartis USD 31.71B 95M 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
TG Therapeutics USD 171.89M 11.68M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


TG Therapeutics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.